首页 | 本学科首页   官方微博 | 高级检索  
   检索      

重组质粒与重组蛋白共免疫诱导HBsAg特异性T细胞免疫抑制
引用本文:杜小刚,王军朋,康有敏,王肖,赵干,王宾.重组质粒与重组蛋白共免疫诱导HBsAg特异性T细胞免疫抑制[J].微生物学报,2009,49(7):938-942.
作者姓名:杜小刚  王军朋  康有敏  王肖  赵干  王宾
作者单位:1. 四川农业大学生命科学与理学院应用生物物理与免疫工程实验室,雅安,625014
2. 中国农业大学生命科学院,农业生物国家重点实验室,北京,100094
基金项目:国家自然科学基金(30771602)
摘    要:摘要:【目的】为了探索治疗急性乙型肝炎和爆发性乙型肝的新策略,本研究将HBV DNA疫苗和相应抗原的蛋白质分子联合免疫小鼠,旨在探讨联合免疫对小鼠抗原特异性T细胞增殖反应的影响。【方法】我们将HBV DNA疫苗(pcDS2)和相应抗原蛋白质分子(HBsAg)联合免疫BALB/c小鼠;分别在第0、2和4周进行免疫,在第6周用ELISA方法检测抗-HBs IgG效价,MTT和流式细胞仪检测T细胞增殖反应,及流式细胞仪检测细胞因子表达水平。【结果】pcDS2和HBsAg联合免疫组小鼠的抗-HBs水平显著提高;免疫小鼠的T细胞体外经HBsAg刺激后, 联合免疫组刺激指数(SI)明显降低;经流式细胞仪检测进一步证实联合免疫组T细胞增殖反应被显著抑制;联合免疫组T细胞表达IL-10和Foxp3水平显著升高。【结论】pcDS2和HBsAg联合免疫能诱导产生特异性体液免疫应答,但不能诱导产生抗原特异性T细胞增殖反应;T细胞增殖反应被显著抑制可能与T细胞表达IL-10和Foxp3上调有关;本研究为急性乙型肝炎和爆发性乙型肝炎治疗及HBV疫苗的研究奠定了基础。

关 键 词:关键词:免疫抑制  T细胞增殖  表面抗原  DNA疫苗
收稿时间:2009/3/11 0:00:00
修稿时间:4/8/2009 12:00:00 AM

Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg
Xiaogang Du,Junpeng Wang,Youming Kang,Wang Xiao,Gan Zhao and Bin Wang.Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg[J].Acta Microbiologica Sinica,2009,49(7):938-942.
Authors:Xiaogang Du  Junpeng Wang  Youming Kang  Wang Xiao  Gan Zhao and Bin Wang
Institution:Appled Biophysics and Immune Engineering Laboratory, College of Life and Physical Science, Sichuan Agricultural University, Ya'an 625014, China;State Key Laboratory for Agro-Biotechnology, Department of Microbiology and Immunology, College of Biological Science, China Agricultural University, Beijing 100193, China;State Key Laboratory for Agro-Biotechnology, Department of Microbiology and Immunology, College of Biological Science, China Agricultural University, Beijing 100193, China;State Key Laboratory for Agro-Biotechnology, Department of Microbiology and Immunology, College of Biological Science, China Agricultural University, Beijing 100193, China;State Key Laboratory for Agro-Biotechnology, Department of Microbiology and Immunology, College of Biological Science, China Agricultural University, Beijing 100193, China;State Key Laboratory for Agro-Biotechnology, Department of Microbiology and Immunology, College of Biological Science, China Agricultural University, Beijing 100193, China
Abstract:Objective] To explore a new therapeutic strategy against acute hepatitis B and fulminant hepatitis B, we studied effect of co-immunization with HBV DNA and HBsAg on the T cell proliferation reaction. Methods] We immunized the BALB/ c mice with HBV DNA vaccine (pcDS2) plus HBsAg by intramuscular injection. The immunization was performed on week 0, 2 and 4. The anti-HBs(IgC)antibody titer, T lymphocyte proliferation reaction , and the expression of IL-10 and Foxp3 in CD3 + T cell were detected on week 6. Results] The anti-HBs IgC titer induced by pcDS2 plus HBsAg group was higher than that induced by pcDS2, or HBsAg alone. Compared to mice immunized with pcDS2, or HBsAg alone, the stimulated index (SI) of T cell proliferation induced by the pcDS2 plus HBsAg group tested by MTT methods decreased. Besides, the immune suppression of T cell proliferation response induced by co-immunization group was further confirmed by flow cytometry. Finally, the expression of IL-10 and Foxp3 in CD3+ T cell was up-regulated in the co-immunization group significantly. Conclusion] The co-immunization of HBV DNA vaccine and HBsAg can induce the humoral immune response, but cannot induce antigen specific T cell proliferation reaction. Besides, the immune suppression induced by co-immunization may be correlated with the expression of IL-10 and Foxp3.
Keywords:Keywords: immune suppression  T cell proliferation  HBsAg  DNA vaccine
本文献已被 万方数据 等数据库收录!
点击此处可从《微生物学报》浏览原始摘要信息
点击此处可从《微生物学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号